GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Alpha Healthcare Acquisition Corp III (NAS:ALPA) » Definitions » EV-to-EBITDA

Alpha Healthcare Acquisition III (Alpha Healthcare Acquisition III) EV-to-EBITDA : -103.43 (As of May. 11, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Alpha Healthcare Acquisition III EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Alpha Healthcare Acquisition III's enterprise value is $193.72 Mil. Alpha Healthcare Acquisition III's EBITDA for the trailing twelve months (TTM) ended in Mar. 2023 was $-1.87 Mil. Therefore, Alpha Healthcare Acquisition III's EV-to-EBITDA for today is -103.43.

The historical rank and industry rank for Alpha Healthcare Acquisition III's EV-to-EBITDA or its related term are showing as below:

ALPA' s EV-to-EBITDA Range Over the Past 10 Years
Min: -415.37   Med: 0   Max: 0
Current: -103.43

ALPA's EV-to-EBITDA is not ranked
in the Diversified Financial Services industry.
Industry Median: 8.75 vs ALPA: -103.43

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-11), Alpha Healthcare Acquisition III's stock price is $9.80. Alpha Healthcare Acquisition III's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2023 was $0.010. Therefore, Alpha Healthcare Acquisition III's PE Ratio for today is 980.00.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Alpha Healthcare Acquisition III EV-to-EBITDA Historical Data

The historical data trend for Alpha Healthcare Acquisition III's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alpha Healthcare Acquisition III EV-to-EBITDA Chart

Alpha Healthcare Acquisition III Annual Data
Trend Dec21 Dec22
EV-to-EBITDA
-405.58 -118.64

Alpha Healthcare Acquisition III Quarterly Data
Jan21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only -304.21 -209.45 -203.36 -118.64 -107.12

Competitive Comparison of Alpha Healthcare Acquisition III's EV-to-EBITDA

For the Shell Companies subindustry, Alpha Healthcare Acquisition III's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alpha Healthcare Acquisition III's EV-to-EBITDA Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Alpha Healthcare Acquisition III's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Alpha Healthcare Acquisition III's EV-to-EBITDA falls into.



Alpha Healthcare Acquisition III EV-to-EBITDA Calculation

Alpha Healthcare Acquisition III's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=193.720/-1.873
=-103.43

Alpha Healthcare Acquisition III's current Enterprise Value is $193.72 Mil.
Alpha Healthcare Acquisition III's EBITDA for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.87 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Alpha Healthcare Acquisition III  (NAS:ALPA) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Alpha Healthcare Acquisition III's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=9.80/0.010
=980.00

Alpha Healthcare Acquisition III's share price for today is $9.80.
Alpha Healthcare Acquisition III's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.010.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Alpha Healthcare Acquisition III EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Alpha Healthcare Acquisition III's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Alpha Healthcare Acquisition III (Alpha Healthcare Acquisition III) Business Description

Traded in Other Exchanges
N/A
Address
1177 Avenue of the Americas, 5th Floor, New York, NY, USA, 10036
Website
Alpha Healthcare Acquisition Corp III is a blank check company. It is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.
Executives
Rajiv Shukla director, 10 percent owner, officer: Chief Executive Officer EMERALD VIEW SUITE 400, 2054 VISTA PARKWAY, WEST PALM BEACH FL 33411
Patrick A Sturgeon officer: CFO and Secretary 600 LEXINGTON AVENUE 33 FLOOR, NEW YORK NY 10022
William Woodward director ANTHEM VENTURE PARTNERS, 225 ARIZONA AVENUE, SUITE 200, SANTA MONICA CA 90401
Darlene T Deremer director 200 CENTRAL AVENUE, SUITE 1850, ST. PETERSBURG FL 33701
Ahac Sponsor Iii Llc 10 percent owner 1177 AVENUE OF THE AMERICAS, 5TH FLOOR, NEW YORK NY 10036
Eugene L Podsiadlo director C/O ALPHA HEALTHCARE CORP. III, 1177 AVENUE OF THE AMERCIAS 5TH FLOOR, NEW YORK NY 10036